Regulation And Legal
Twenty First Century Pharma MD Appeals CIRP Admission
NCLAT hears appeal by suspended MD challenging CIRP admission order against Twenty First Century Pharmaceuticals.
Appellant contests admission on grounds of limitation and lack of proper authorization
